semaglutide and antipsychotics Semaglutide, a second-generation GLP-1 receptor agonist, was associated with significantly reduced body weight other metabolic factors in adults with schizophrenia, prediabetes, and overweight/obesity compared with placebo, research from September 🚨 Antipsychotic-induced weight gain is

Sullenger BA, Gilboa E

J.QiZ.-Y

People who called in reported accidental overdoses and dosing errors that led to digestive symptoms such as vomiting, nausea and stomach pain

sat down with Joe Rogan and dropped one of the biggest announcements in the history of functional wellness: roughly 14 of the 19 peptides the FDA had effectively banned from compounding pharmacies were coming back

In the SURMOUNT-5 head-to-head trial in 2025, tirzepatide beat semaglutide directly, about 20.2% versus 13.7%

It feels like a tool that can help you take charge of your health, and it feels like one more object youre afraid of using wrong